About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
EventsCardiawave attended the CNRS Roundtable at Vivatech 2023 – June 14 – Paris Jun 13, 2023 © CNRS READ MORE
EventsCardiawave has secured the 2nd position among 50 exceptional participants for the prestigious John DeHann Foundation Award – May 15 – Paris Jun 8, 2023 © Cardiovascular News READ MORE
Scientific PublicationsSystematic brain magnetic resonance imaging and safety evaluation of non-invasive ultrasound therapy for patients with severe symptomatic aortic valve stenosis May 24, 2023 READ MORE
EventsCardiawave has been selected to participate to the Jon DeHaan Foundation Award Competition during EuroPCR Innovators’ Day – May 15 – Paris May 11, 2023 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
